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Key points
 In vascular smooth muscle cells (VSMCs), activation of Ca2+-permeable store-operated
channels (SOCs) composed of canonical transient receptor potential channel 1 (TRPC1)
subunits mediates Ca2+ entry pathways that regulate contraction, proliferation and migration,
which are processes associated with vascular disease.
 Activation of TRPC1-based SOCs requires protein kinase C (PKC) activity, which is proposed
to phosphorylate TRPC1 proteins to promote channel opening by phosphatidylinositol
4,5-bisphosphate (PIP2). We investigated the identity of the PKC isoform involved in activating
TRPC1-based SOCs in rat mesenteric artery VSMCs.
 TRPC1-based SOCs were reduced by PKCδ inhibitors and knockdown of PKCδ expression.
Store depletion induced interactions between TRPC1 and PKCδ and PKCδ-dependent
phosphorylation of TRPC1. Furthermore, generation of store-operated interactions between
PIP2 and TRPC1 and activation of TRPC1-based SOCs by PIP2 required PKCδ.
 These findings reveal that PKCδ activity has an obligatory role in activating TRPC1-based
SOCs, through regulating PIP2-mediated channel opening.
Abstract In vascular smooth muscle cells (VMSCs), stimulation of Ca2+-permeable canonical
transient receptor potential channel 1 (TRPC1)-based store-operated channels (SOCs) mediates
Ca2+ entry pathways that regulate cell contraction, proliferation and migration, which are
processes associated with vascular disease. It is therefore important to understand how
TRPC1-based SOCs are activated. Stimulation of TRPC1-based SOCs requires protein kinase
C (PKC) activity, with store-operated PKC-dependent phosphorylation of TRPC1 essential for
channel opening by phosphatidylinositol 4,5-bisphosphate (PIP2). Experimental protocols used
to activate TRPC1-based SOCs suggest that the PKC isoform involved requires diacylglycerol
(DAG) but is Ca2+-insensitive, which are characteristics of the novel group of PKC isoforms (δ, ε,
η, θ). Hence, the present study examined whether a novel PKC isoform(s) is involved in activating
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TRPC1-based SOCs in contractile rat mesenteric artery VSMCs. Store-operated whole-cell cation
currents were blocked by Pico145, a highly selective and potent TRPC1/4/5 channel blocker
and T1E3, a TRPC1 blocking antibody. PKCδ was expressed in VSMCs, and selective PKCδ
inhibitory peptides and knockdown of PKCδ expression with morpholinos oligomers inhibited
TRPC1-based SOCs. TRPC1 and PKCδ interactions and phosphorylation of TRPC1 induced
by store depletion were both reduced by pharmacological inhibition and PKCδ knockdown. In
addition, store-operated PIP2 and TRPC1 interactions were blocked by PKCδ inhibition, and
PKCδ was required for PIP2-mediated activation of TRPC1 currents. These results identify the
involvement of PKCδ in stimulation of TRPC1-based SOCs and highlight that store-operated
PKCδ activity is obligatory for channel opening by PIP2, the probable activating ligand.
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Introduction
Store-operated channels (SOCs) are Ca2+-permeable
plasmalemmal ion channels activated by depletion
of cytosolic endo/sarcoplasmic (ER/SR) Ca2+ stores
(Baudel et al. 2020). In vascular smooth muscle cells
(VSMCs), SOCs are stimulated by vasoconstrictors that
activate the Gαq protein-coupled receptor signalling
pathway leading to phospholipase C (PLC) activity,
phosphatidylinositol 4,5-bisphosphate (PIP2) hydro-
lysis, inositol 1,4,5-trisphosphate (IP3) generation and
IP3-mediated depletion of SR Ca2+ stores. As such
SOCs induce Ca2+ entry pathways that regulate
vasoconstrictor-mediated contraction, proliferation and
migration, and are considered drug targets for treatment of
vascular diseases such as hypertension and atherosclerosis.
There is substantial evidence that SOCs represent a
diverse family of ion channels with differing molecular
composition, activation mechanisms and functions
(Albert & Large, 2003; Albert et al. 2007; 2009; Cheng
et al. 2013; Prakriya & Lewis, 2015; Ong et al. 2015). In
native contractile VSMCs, SOCs have relatively low Ca2+
permeability, linear current–voltage (I–V) rectification
properties, a single channel conductance of 2–3 pS and
are composed of canonical transient receptor potential
(TRPC) channels (Trepakova et al. 2001; Xu & Beech,
2001; Albert & Large, 2002a; Bergdahl et al. 2005; Liu
et al. 2005a,b; Xu et al. 2005a; Albert et al. 2006; Saleh
et al. 2006; 2008; 2009a; Shi et al. 2012a, 2014, 2016,
2017a). It is proposed that molecular composition involves
a heteromeric TRPC1/C5 template with TRPC1 being
the critical subunit for conferring activation by store
depletion, hence the term TRPC1-based SOCs (Xu &
Beech, 2001; Xu et al. 2005a; Saleh et al. 2008; Shi
et al. 2012a). In comparison, synthetic VSMCs that
are involved in cell proliferation, migration and growth
and are associated with more pathological functions
exhibit TRPC1-based SOCs and also SOCs with properties
similar to Orai1-based calcium release-activated channels
(CRACs) such as high Ca2+ permeability, pronounced
inward rectification, single channel conductance in the fS
range and composition of Orai1 proteins (Berra-Romani
et al. 2008; Beech, 2012; Trebak, 2012, Prakriya & Lewis,
2015). It is important to highlight that, in the present study,
we examined activation mechanisms of TRPC1-based
SOCs in freshly isolated and primary cultured single
VSMCs and tissue lysates that have a native contra-
ctile phenotype (Shi et al. 2016, 2017a) and probably
do not involve Orai1 proteins (Shi et al. 2017b). These
TRPC1-based SOCs are probably important in regulating
contractility and switching of VSMCs from contra-
ctile to synthetic phenotypes (Berra-Romani et al. 2008;
Matchkov et al. 2012).
How store depletion stimulates TRPC-based SOCs is
controversial, especially compared to Orai1-based CRACs
for which it is well-established that store depletion induces
the ER/SR store Ca2+ sensor stromal interaction molecule
1 (STIM1) to oligomerize and translocate to the plasma
membrane where it interacts with Orai1 to induce channel
assembly and gating (Prakriya & Lewis, 2015). However,
there is growing evidence that store depletion also activates
TRPC-based SOCs through STIM1-mediated processes,
potentially involving direct interactions between TRPC
and Orai1 proteins (Liao et al. 2014), activation of
Orai1-based CRACs as a prerequisite for TRPC1 channel
opening (Ambudkar et al. 2017), and direct interactions
between TRPC and STIM1 proteins (Worley et al. 2007;
Yuan et al. 2009; Lee et al. 2014; Asanov et al. 2015). In
native contractile VSMCs, our recent work indicates that
store depletion stimulates TRPC1-based SOCs through
a novel STIM1-mediated Gαq/PLCβ1 pathway, which
probably induces channel opening by regulating inter-
actions between protein kinase C and PIP2 (Shi et al. 2016,
2017a).
There is considerable evidence that protein kinase C
(PKC) activity is critical for activation of TRPC1-based
SOCs in native contractile VSMCs (Large et al.
2009; Albert, 2011). PKC inhibitors prevent activation
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of TRPC1-based SOCs and reduce store-operated
phosphorylation of TRPC1, and PKC activators stimulate
TRPC1-based SOCs (Saleh et al. 2008, 2009a; Shi
et al. 2012a, 2016). Activation of TRPC1-based SOCs
and phosphorylation of TRPC1 by physiological vaso-
constrictors are also reduced by PKC inhibitors (Albert
& Large, 2002b; Saleh et al. 2006; 2009b; Shi et al. 2012b,
2014, 2016). It is proposed that PKC activity stimulates
opening of TRPC1-based SOCs through phosphorylation
of TRPC1 proteins to promote PIP2 binding that acts as
the activating ligand (Shi et al. 2014, 2016, 2017a). As
such, activation of TRPC1-based SOCs by store depletion
or PKC activators is inhibited by anti-PIP2 antibodies and
pre-treatment with PI4-kinase inhibitors which deplete
PIP2 levels (Saleh et al. 2009a; Shi et al. 2012b). In addition,
activation of TRPC1-based SOCs by the water soluble
PIP2 analogue diC8-PIP2 is prevented by PKC inhibitors
(Saleh et al. 2009a; Shi et al. 2012b). These results indicate
that interactions between PKC activity and PIP2 have
obligatory roles in activation of TRPC1-based SOCs; PKC
cannot activate TRPC1-based SOCs without PIP2 and
vice versa (Baudel et al. 2020). The present study further
examines the importance of PKC activity in activating
TRPC1-based SOCs by investigating the PKC isoform(s)
involved.
The PKC family comprises of at least 11 homo-
logous serine/threonine kinases divided into three
groups according to their basic structure and activation
requirements: conventional PKC isoforms (α, βI, βII and
γ) require both Ca2+ and diacylglyerol (DAG), novel
PKC isoforms (δ, ε, η and θ) require DAG but are
Ca2+-insensitive, and atypical PKC isoforms (ζ, ι and λ)
are activated by lipid mediators such as phosphatidylserine
and do not require Ca2+ or DAG (Salamanca & Khalil,
2005; Ringvold & Khalil, 2017).
Many of these PKC isoforms are expressed in VSMCs
and are proposed to regulate several physiological and
pathological processes, including those reported to involve
a role for TRPC1-based SOCs (Salamanca & Khalil, 2005;
Ding et al. 2011; Fan et al. 2014; Ringvold & Khalil, 2017).
In native contractile VSMCs, stimulation of TRPC1-based
SOCs and PKC-dependent phosphorylation of TRPC1
by store-depletion requires PLCβ1 activity (Shi et al.
2016), DAG activates TRPC1-based SOCs through a
PKC-dependent mechanism (Saleh et al. 2006; 2008;
Large et al. 2009; Albert, 2011), and TRPC1-based SOCs
are activated by store depleting agents that probably
increase (e.g. the SR Ca2+-ATPase inhibitor cyclopiazonic
acid), decrease (e.g. the cell-impermeable and -permeable
high affinity Ca2+ chelators BAPTA and BAPTA-AM) or
produce little change in [Ca2+]i (e.g. the cell-permeable
low affinity Ca2+ chelator TPEN). These results suggest
that the PKC isoform involved requires DAG, although it is
probably Ca2+-insensitive; these are characteristics of the
novel group of PKC isoforms. These ideas on the identity
of the PKC isoform involved form the basis of the present
work, and our findings indicate that the PKCδ novel iso-
form is the probable candidate involved in activation of




All animal procedures were carried out in accordance
with guidelines laid down by St George’s, University of
London Animal Welfare Committee, and conform with
the principles and regulations described by the Service
Project Licence: 70/8512, and also to the principles and
regulations of The Journal of Physiology as described by
Grundy (2015). Male Wistar rats (8–12 weeks old) were
used for the purpose of the present study. Rats were
supplied from Charles River (Margate, UK) and housed
and maintained in standard sized plastic cages at the
Biological Research Facility at St George’s, University
of London, under a 12:12 h light/dark photocycle, at
18–20 °C and 50% relative humidity, with water and
laboratory rodent diet (Specialist Dietary Services, UK)
available ad libitum. Animals were culled by cervical
dislocation in accordance with the UK Animals Scientific
Procedures Act of 1986 and as revised by European
Directive 2010/63/EU.
Cell isolation and tissue lysates
Mesenteric arteries were dissected and cleaned of adherent
fat in physiological salt solution containing (mmol L−1):
126 NaCl, 6 KCl, 10 glucose, 11 Hepes, 1.2 MgCl2, and 1.5
CaCl2 with pH adjusted to 7.2 with 10 mol L−1 NaOH.
Single VSMCs were enzymatically dispersed and tissue
lysates prepared as described previously (Shi et al. 2016,
2017a).
PKCδ knockdown
Knockdown of PKCδ was performed by trans-
fection of vessel segments with morpholino anti-sense
oligonucleotides as described previously (Stott et al.
2018). PKCδ morpholino oligomers and a control
oligomer containing five mismatched nucleotides (10 μM;
Genetools, Philomath, OR, USA) were mixed with
lipofectamine 2000 (Life Technologies, Carlsbad, CA,
USA) in Opti-MEM and left at room temperature for
2 h. Mesenteric artery segments were cultured with this
mix in Dulbecco’s modified Eagle’s medium F-12 with 1%
penicillin/streptomycin at 37°C for 48 h. Vessel segments
were then enzymatically dispersed into single VSMCs or
used as tissue lysates as required.
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Electrophysiology
Whole-cell and cell-attached patch clamp techniques were
used to record TRPC1-based SOCs with an Axopatch
200B amplifier (Axon Instruments, Union City, CA, USA)
at room temperature (20–23°C) using bath and patch
pipette solutions, data analysis and experimental protocols
as described previously (Shi et al. 2017a). In experiments
investigating the effects of phorbol 12,13-dibutyrate,
a phorbol ester and PKC activator, and diC8-PIP2 on
whole-cell cation currents, 750 ms duration voltage ramps
from +100 mV to −150 mV were applied every 30 s from
a holding potential of 0 mV. The patch pipette solution
contained (mM): 126 CsCl, 1.2 MgCl2, 10 nHepes, 11
glucose, 10 BAPTA, 4.8 CaCl2, 100 nM free internal
Ca2+ concentration as calculated using MaxChelator
(https://somapp.ucdmc.ucdavis.edu/pharmacology/bers/
maxchelator), 1 Na2ATP, 0.2. NaGTP, pH 7.2 with Tris.
The external solution contained (mM): 126 NaCl, 1,5
CaCl2, 10 Hepes, 11 glucose, 0.1. DIDS, 0.1 niflumic acid
and 0.005 nicardipine, pH 7.2 with NaOH.
Immunoprecipitation and western blotting
Freshly isolated or cultured vessel segments were pre-
pared for immunoprecipitation, one-dimensional protein
gel electrophoresis and immunoblotting as described
previously (Shi et al. 2017a). The primary anti-
bodies used were: mouse anti-PKCε (dilution 1:500;
sc-1681; Santa Cruz Biotechnology, Santa Cruz, CA,
USA), mouse anti-PKCθ (dilution 1:500; sc-1680;
Santa Cruz Biotechnology), mouse anti-PKCη (dilution
1:500; sc-136 036; Santa Cruz Biotechnology) and
rabbit anti-PKCδ (dilution 1:1000; ab182126; Abcam,
Cambridge, MA, USA). Rabbit anti-TRPC1 antibody
(1 μg mL−1) was generated by GenScript (Piscataway,
NJ, USA) using peptide sequences from a previously
characterized putative extracellular region (Xu & Beech,
2001). Visualization were performed using anti-rabbit and
anti-mouse secondary antibodies conjugated to IRDye
800RD or IRDye 680CW (dilution 1:10 000; Li-Cor
Biosciences, Cambridge, UK) as appropriate and the
Odyssey Infrared Imaging System (Li-Cor Biosciences).
Protein band intensities were measured using Image
Studio software (Li-Cor Biosciences) and normalized to
smooth muscle actin (dilution 1:2000; #ab5694; Abcam)
when quantified.
Immunofluorescence
Single VSMCs were fixed with 4% (w/v) paraformaldehyde
for 15 min, cells were treated with 0.1 mol L−1 glycine
for 5 min and permeabilized with phosphate-buffered
saline (PBS) containing 0.1% (v/v) Triton X-100
(PBS-T) for 15 min at room temperature. Cells were
then incubated with PBS-T containing 1% (w/v) BSA
for 1 h at room temperature to block non-specific
binding of antibodies. Immunostaining was performed
with mouse anti-PKCε (dilution 1:500; sc-1681; Santa
Cruz Biotechnology), mouse anti-PKCθ (dilution 1:200;
sc-1680; Santa Cruz Biotechnology), rabbit anti-PKCη
(dilution 1: 200; ab4134; Abcam), rabbit anti-PKCδ
(dilution 1:1000; ab182126; Abcam) overnight at 4°C.
Cells were then washed and incubated with a 488
fluorophore-conjugated donkey anti-goat secondary anti-
body (dilution 1:1000; A-11 055; Alexa Fluor; Thermo
Fisher Scientific, Waltham, MA, USA) for 1 h at
room temperature. Unbound secondary antibodies were
removed by washing with PBS, and nuclei were labelled
with 4′,6-diamidino-2-phenylindole mounting medium
(Sigma, Poole, UK). Control experiments were performed
by omitting either primary or secondary antibodies. Cells
were imaged using an A1R confocal microscope (Nikon,
Tokyo, Japan). PIP2 immunofluorescence experiments
were performed in the presence of saponin with rabbit
anti-PIP2 (sc-53 412, 1:50; Santa Cruz Biotechnology) as
described previously (Edimo et al. 2016).
Proximity ligation assay
Interactions between different proteins were investigated
with a Duolink R© in situ detection kit (Sigma) as described
previously (Shi et al. 2017a). Single VSMCs were fixed and
permeabilized as per immunofluorescence and blocking
was performed with Duolink blocking buffer for 1 h
at 37°C. Cells were then incubated with appropriate
antibodies overnight at 4°C as per immunofluorescence
experiments plus mouse anti-P-Ser (dilution 1:100;
sc-16B4; Santa Cruz Biotechnology), mouse anti-P-Thr
(dilution 1:100; sc-5267; Santa Cruz Biotechnology),
mouse anti-TRPC1 (dilution 1:100; sc-133 076; Santa Cruz
Biotechnology) and rabbit anti-TRPC5 (T5E3), which was
generated by GenScript using peptide sequences from
a previously characterized putative extracellular region
(1 μg mL−1) ((Xu & Beech, 2001; Xu et al. 2005a,b). The
rest of the protocol was conducted in accordance with
the manufacturer’s instructions. Fluorescent puncta were
visualized with an A1R confocal microscope and images
were analysed with ImageJ Fiji (https://fiji.sc). The mean
number of puncta per cell was calculated by counting the
number of particles across a z-stack of the cell.
Reagents
Pico145 was a generous gift provided by Robin S Bon
and David J Beech (University of Leeds, Leeds, UK).
The cell permeable PKCδ inhibitor, δV1-TAT peptide
(RRRQRRKKRGY-SFNSYELGSL) was synthesized by
Mimotopes (Wirral, UK). PKCδ non-permeable δPKC8-17
peptide inhibitor (SFNSYELGSL) was purchased from
C© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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AnaSpec (AnaSpec, EGT Corporate Headquarters,
Fremont, CA, USA). PKCε peptide inhibitor was
purchased from Santa Cruz Biotechnology. All other
drugs were purchased from Sigma or Tocris (Abingdon,
UK). Agents were dissolved in distilled H2O or 0.1%
DMSO. DMSO alone had no effect on whole-cell or single
channel currents.
Statistical analysis
All statistical analysis was performed using Prism, version
8 (GraphPad Software Inc., San Diego, CA, USA). Data
were calculated as the mean ± SD, with n indicating
the number of data points. Data points were generated
from at least three different isolated VSMCs or tissue
lysate preparations. To compare between two or more
I–V relationships, two-way ANOVA with Tukey’s multiple
comparisons test was used, and differences in means at
−80 mV are reported. To compare between two data
sets, paired or unpaired t tests were used. P < 0.05 was
considered statistically significant.
Results
PKC-dependent store-operated currents are
composed of TRPC1 subunits in rat mesenteric
artery VSMCs
In our first series of experiments, we confirmed that
PKC-dependent TRPC1-based SOCs are functionally
expressed in native contractile VSMCs from freshly iso-
lated rat mesenteric arteries using a highly selective and
potent TRPC1/C4/C5 channel blocker Pico145 (Rubaiy
et al. 2017), an externally-acting TRPC1 blocking antibody
T1E3 (Xu & Beech, 2001, Xu et al. 2005b) and the pan-PKC
isoform selective inhibitor GF109203X. Figure 1A shows
that passive depletion of internal Ca2+ stores, following
cell dialysis with a patch pipette solution containing high
concentrations of BAPTA and no added Ca2+, induced
whole-cell cation currents that had a relatively linear I–V
relationship, an Erev between 0 mV and +20 mV, with
a mean control amplitude of −1.15 ± 0.62 pA pF–1 at
−80 mV which increased to a mean peak amplitude
of −2.74 ± 0.88 pA pF–1 (n = 6, p = 0.0015) and
reduced to −0.89 ± 0.35 pA pF–1 by bath application
of Pico145 (n = 6, p = 0.0002, two-way ANOVA,
Tukey’s multiple comparisons test). Figure 1B and C
show that bath application of T1E3 and G109203X
also inhibited store-operated whole-cell currents, with
mean peak amplitudes at −80 mV reduced respectively
from −2.96 ± 0.92 pA pF–1 to −0.84 ± 0.43 pA pF–1
(n = 6, p = 0.0001) and from −2.14 ± 0.92 pA pF–1
to −0.91 ± 0.45 pA pF–1 (n = 7, p = 0.0051, two-way
ANOVA, Tukey’s multiple comparisons test).
There is considerable evidence that heteromeric
TRPC1/C5 molecular structures compose TRPC1-based
SOCs in VSMCs from different rabbit, mouse and human
vascular beds (see Introduction). In proximity ligation
assay (PLA) studies, Figure 2 shows that fluorescent puncta
with a mean number per cell of 51.5 ± 12.6 (n = 14)
produced using anti-TRPC1 and anti-TRPC5 antibodies
were present at (or close to) the plasma membrane in
freshly isolated rat mesenteric artery VSMCs.
These findings clearly confirm that PKC-dependent
TRPC1-based SOCs are functionally expressed in native
contractile rat mesenteric artery VSMCs, similar to pre-
vious studies in VSMCs from different rabbit, mouse and
human vascular preparations (see Introduction).
Figure 1. TRPC1 compose
PKC-dependent SOCs in native
contractile VSMCs
A, representative trace and mean I–V
relationships showing that the development
of store-operated whole-cell currents from
control to peak levels in freshly isolated rat
mesenteric artery VSMCs following
obtaining whole-cell configuration (wc) was
inhibited by bath application of Pico145.
Vertical deflections represent currents
evoked by voltage ramps from +100 mV to
−150 mV (750 ms duration) every 30 s
from a holding potential of 0 mV. B and C,
Mean data showing that bath applications
of T1E3 (1 μg mL−1) and GF109203X
(3 μM) inhibited store-operated whole-cell
currents.
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PKCδ is the dominant novel PKC isoform in VSMCs
The PKC isoform involved in activating TRPC1-based
SOCs in VSMCs requires DAG but is Ca2+ insensitive and
is probably a member of the novel PKC isoform family (see
Introduction). We therefore investigated the expression of
novel PKC isoforms in tissue lysates from freshly isolated
rat mesenteric arteries. We used brain lysates as positive
controls where novel PKC isoforms have been previously
identified (Fleegal et al. 2005; Popp et al. 2006; Callender
& Newton, 2017; Wang et al. 2019; Yang et al. 2019).
Figure 3a shows PKCδ expression with relatively low
levels or little expression of PKCε, PKCη and PKCθ were
found in tissue lysates from rat mesenteric arteries. Using
the same anti-PKC novel isoform antibodies, expression of
PKCδ, PKCε, PKCηand PKCθ was present in brain lysates.
In addition, Figure 3b shows that immunocytochemical
studies revealed PKCδ staining at (or close to) the plasma
membrane of VSMCs with little staining recorded for
PKCε, PKCη and PKCθ isoforms.
PKCδ activity is essential for activation of
TRPC1-based SOCs
In our next series of experiments, we examined whether
pharmacological inhibition of PKCδ and knockdown of
PKCδ expression using morpholino technology resulted
in an anticipated decrease in activation of TRPC1-based
SOCs. We focused on the PKCδ isoform based on the
expression studies detailed above and previous data on
the expression and function of PKCδ in vascular smooth
muscle (Salamanca & Khalil, 2005; Ringvold & Khalil,
2017).
Figure 4A reveals that store-operated whole-cell
TRPC1-based currents were inhibited by bath application
of the cell-permeable PKCδ inhibitor δV1-TAT, with mean
peak amplitude reduced from −6.18 ± 2.34 pA pF–1 to
−1.26 ± 0.57 pA pF–1 at −80 mV (n = 6, p = 0.0001,
two-way ANOVA, Tukey’s multiple comparisons test).
Figure 2. Expression of TRPC1-TRPC5 interactions in native
contractile VSMCs
Representative PLA images from two different freshly isolated rat
mesenteric artery VSMCs showing the association between TRPC1
and TRPC5. These images, and other PLA images, represent puncta
observed across a z-stack of each cell. Scale bar = 10 μm.
Figure 4B also shows that following inclusion of the
cell-impermeable PKCδ peptide inhibitor δPKC8-17 in
the patch pipette solution store depletion induced a
small whole-cell TRPC1-based current with mean control
amplitude increasing from −0.97 ± 0.27 pA pF–1 to a
mean peak amplitude of −2.01 ± 1.1 pA pF–1 at −80 mV
(n = 6, p = 0.0902, two-way ANOVA, Tukey’s multiple
comparisons test).
Because expression of PKCε was also observed in
VSMCs (Fig. 3) and other studies have reported the
expression of PKCε in the vasculature (Salamanca &
Khalil, 2005; Ringvold & Khalil, 2017), we investigated the
potential contribution of this PKC isoform in activating
store-operated TRPC1-based SOCs. Figure 4C shows
that, following inclusion of a PKCε-specific peptide
inhibitor in the patch pipette solution, store depletion
activated whole-cell TRPC1 currents with a mean control
amplitude increasing from −0.84 ± 0.21 pA pF–1 to
−3.39 ± 1.42 pA pF–1 at −80 mV (n = 5, p = 0.0006),
which was subsequently inhibited by bath application of
δV1-TAT to −0.99 ± 0.56 pA pF–1 (n = 5, p = 0.0012,
two-way ANOVA, Tukey’s multiple comparisons
test).
Figure 5A shows that incubation of freshly isolated rat
mesenteric artery segments with anti-sense morpholino
oligomers against PKCδ for 48 h significantly decreased
protein expression of PKCδ by 50% compared to a
mismatched oligomer (n = 3, p = 0.0202, unpaired t
test). Figure 5B shows that, in VSMCs isolated from vessel
segments expressing mismatched (scrambled) oligomers,
store depletion induced whole-cell TRPC1 currents with
relative linear rectification and a mean control amplitude
at −80 mV that increased from −1.07 ± 0.68 pA pF–1
to a mean peak amplitude of −2.57 ± 0.89 pA pF–1
(n = 9, p = 0.0003, two-way ANOVA, Tukey’s multiple
comparisons test), which were similar to currents recorded
from freshly isolated VSMCs (Figs 1 and 4). By contrast,
Figure 5B shows that, in VSMCs expressing specific
PKCδ oligomers, store depletion activated small whole-cell
TRPC1 currents, with the control mean amplitude at
−80 mV increasing from −1.05 ± 0.59 pA pF–1 to
a mean peak amplitude of −1.36 ± 0.69 pA pF–1
(n = 10, p = 0.8240, two-way ANOVA, Tukey’s
comparisons test). As such, mean peak amplitudes of
store-operated TRPC1 current at −80 mV were greatly
reduced in VSMCs expressing specific PKCδ compared
to scrambled oligomers (p = 0.0051, two-way ANOVA,
Tukey’s comparisons test).
Store depletion induces TRPC1 and PKCδ interactions
and PKCδ-dependent phosphorylation of TRPC1
The above pharmacological and molecular evidence
indicates that PKCδ activity is essential for activation
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of TRPC1-based SOCs in native contractile VSMCs.
Therefore, we investigated whether store depletion
induced PKCδ and TRPC1 interactions and
PKCδ-dependent phosphorylation of TRPC1 in freshly
isolated rat mesenteric artery tissue lysates and VSMCs.
Immunoprecipitation with anti-TRPC1 antibodies
followed by immunoblotting with an anti-PKCδ anti-
body revealed that interactions between these two
proteins are absent in unstimulated tissue but occur
following incubation with BAPTA-AM or TPEN (Fig. 6A).
Furthermore, the PLA studies shown in Figure 6B
confirmed that interactions between TRPC1 and PKCδ
were absent in unstimulated VSMCs, whereasd robust
puncta at (or close to) the plasma membrane were induced
between TRPC1 and PKCδ following pre-treatment with
BAPTA-AM and TPEN.
Figure 3. Expression of novel PKC
isoforms in native contractile VSMCs
A, representative western blots showing
expression of the novel PKC isoforms PKCε,
PKCθ , PKCη and PKCδ in rat mesenteric
artery VSMCs and brain (B) protein lysates.
B, representative immunocytochemical
images of rat mesenteric VSMCs
immunolabelled with the same anti-novel
PKC isoform antibodies used in (A). Scale
bar = 10 μm.
Figure 4. Pharmacological PKCδ
inhibitors reduce TRPC1-based SOCs
A, representative trace and mean I–V
relationship showing that the peak
amplitude of store-operated whole-cell
TRPC1 currents in freshly isolated rat
mesenteric artery VSMCs was reduced by
bath application of δV1-TAT. B, a small
store-operated whole-cell TRPC1 current
was induced following inclusion of
δPKC8-17 peptide inhibitor in the patch
pipette solution. C, inclusion of εPKC
peptide inhibitor in the patch pipette
appeared to have little effect on the
development of store-operated whole-cell
TRPC1 currents, which were subsequently
inhibited by bath application of δV1-TAT.
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PLA experiments performed with a mixture of
anti-phosphorylated serine/threonine and anti-TRPC1
antibodies revealed a low number of fluorescent puncta in
unstimulated freshly isolated VSMCs, which is indicative
of a low level of basal TRPC1 phosphorylation. Figure 7A
shows that the mean number of puncta per cell was
increased following pre-treatment with BAPTA-AM from
6.1 ± 3.9 (n = 19) to 20.5 ± 9.9 (n = 30, p = 0.0001)
and inhibited by coapplication of δV1-TAT to 8.3 ± 4.2
(n = 25, p = 0.0001, unpaired t test). In addition,
Figure 7B shows that transfection of vessel segments with
specific PKCδ morpholino oligomers also reduced the
BAPTA-AM-induced increase in mean puncta number
compared to scrambled oligomers from 22.4 ± 10.4
(n = 30) to 7.2 ± 4.9 (n = 25, p = 0.0001, unpaired
t test). Importantly, Figure 7A and B shows a similar
mean number of puncta using mismatched oligomers
compared to non-transfected freshly isolated VSMCs
under unstimulated (8.7 ± 4.3, n = 26 vs. 6.1 ± 3.9, n = 19,
p = 0.049) or BAPTA-AM-treated conditions (22.4 ± 10.4,
n = 30 vs. 20.5 ± 9.9, n = 30, p = 0.4653, unpaired t test),
indicating that the transfection process had little effect on
this mechanism.
Taken together, these results indicate that store
depletion induces interactions between TRPC1 and
PKCδ in VSMCs, and that these interactions cause
PKCδ-dependent phosphorylation of TRPC1.
PKCδ mediates store-operated interactions between
PIP2 and TRPC1, as well as PIP2-evoked TRPC1 currents
In our previous work, we identified that PIP2 has an
obligatory role in the activation of TRPC1-based SOCs
Figure 5. Knockdown of PKCδ expression reduces activation of TRPC1-based SOCs
A, representative western blots and mean data showing that PKCδ-specific morpholino oligomers reduced PKCδ
expression in rat mesenteric artery protein lysates compared to scrambled/mismatched oligomers (Scram). Band
intensity was normalized to β-GAPDH to calculate percentage expression (vs. scrambled, n = 3, p = 0.0202,
unpaired t test). B, mean I–V relationships showing that the mean peak amplitude of store-operated whole-cell
TRPC1 currents was reduced in the presence of PKCδ-specific (n = 10) compared to scrambled (n = 9) morpholino
oligomers.
Figure 6. Store depletion induces associations between TRPC1 and PKCδ in native contractile VSMCs
A, representative western blots with anti-TRPC1 and anti-PKCδ antibodies following immunoprecipitation of
freshly isolated rat mesenteric artery tissue lysates with an anti-TRPC1 antibody show that pre-treatment with
the BAPTA-AM and TPEN induced associations between TRPC1 and PKCδ but did not alter TRPC1 expression. B,
representative images of proximity ligation assays from freshly isolated rat mesenteric artery VSMCs showing a
low level of association between TRPC1 and PKCδ in unstimulated VSMCs, which was greatly increased following
pre-treatment with TPEN and BAPTA-AM for 10 min. Scale bars = 10 μm.
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in VSMCs, potentially as the activating ligand, and that
this process requires PKC-dependent phosphorylation of
TRPC1 (see Introduction). Therefore, we investigated
whether store-operated interactions between PIP2
and TRPC1 require PKCδ activity using immuno-
cytochemistry and PLA, and also whether PKCδ is
essential for activation of store-operated whole-cell
TRPC1 currents by PIP2.
In freshly isolated rat mesenteric artery VSMCs,
Figure 8A shows that PIP2 immunostaining was highly
expressed at (or close to) the plasma membrane in
unstimulated cells and BAPTA-AM and δV1-TAT had no
obvious effect on this distribution. With respect to the
staining produced with anti-PIP2 antibodies being related
to endogenous PIP2, Figure 8A shows that pre-treatment
with high concentrations of wortmannin (20 μM),
which inhibits PI-4/PI-5 kinases to reduce PIP2 recycling
and promote PIP2 depletion, produced a considerable
reduction in the PIP2 signal (Suh & Hille, 2005; Saleh et al.
2009a; Shi et al. 2014). In control experiments, TRPC1
immunostaining was unaffected by BAPTA-AM, δV1-TAT
or wortmannin treatment (Fig. 8A). We next adapted this
immunostaining protocol for PLA experiments. Figure 8B
reveals that there was a low level of interactions between
PIP2 and TRPC1 in unstimulated VSMCs, which were
increased by BAPTA-AM from a mean puncta number
per cell of 7.6 ± 5.2 (n = 23) to 34.6 ± 14.1 (n = 24,
p = 0.0001) and inhibited in the presence of δV1-TAT or
following pre-treatment of wortmannin, respectively, to
6.5 ± 2.9 (n = 20, p = 0.0001) and 6.1 ± 3.7 (n = 19,
p = 0.0001, unpaired t test).
In freshly isolated VSMCs, Figure 9A shows that bath
application of the phorbol ester 12,13-dibutyrate (PDBu)
increased whole-cell non-selective cation currents from a
mean control amplitude of −0.71 ± 0.13 pA pF–1 to a
mean peak amplitude of −2.12 ± 0.8 pA pF–1 at −80 mV
(n = 8, p = 0.0001, two-way ANOVA, Tukey’s comparisons
test). By contrast, inclusion of diC8-PIP2 in the patch
pipette solution had no effect on whole-cell cation currents
(−80 mV, −0.75 ± 0.18 vs. −1.0 ± 0.08, n = 5, p = 0.6151,
two-way ANOVA, Tukey’s comparisons test). Figure 9B
shows that dialysing cells with diC8-PIP2 in the patch
pipette solution increased PDBu-activated whole-cell
cation currents, with mean peak amplitude at −80 mV
Figure 7. Store depletion induces
PKCδ-dependent phosphorylation of
TRPC1
A, representative and mean data from
proximity ligation assays showing
pre-treatment with BAPTA-AM (n = 30) for
10 min greatly increased the number of
puncta per cell representing associations
between TRPC1 and phosphorylated serine
and threonine residues compared to control
values (n = 19, p = 0.0001), which was
reduced in the presence of δV1-TAT
(n = 25, p = 0.0001, unpaired t test). B,
representative and mean data from
proximity ligation assays showing that
BAPTA-AM-induced associations between
TRPC1 and phosphorylated serine and
threonine residues were reduced in VSMCs
from vessels transfected with PKCδ-specific
(n = 24, p = 0.0001) compared to
scrambled morpholino oligomers (n = 30,
p = 0.0001, unpaired t test). Scale
bars = 10 μm. ∗∗∗∗p = 0.0001.
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increased from −2.12 ± 0.8 pA pF–1 (n = 8) (Fig. 9A) to
−2.88 ± 0.78 pA pF–1 at −80 mV (n = 7, p = 0.0291,
unpaired t test). Figure 9B also shows that PDBu-evoked
whole-cell cation currents induced in the presence of
diC8-PIP2 were inhibited by bath applications of T1E3 and
δV1-TAT, respectively, to −1.13 ± 0.24 pA pF–1 (n = 5,
p = 0.0001) and −0.84 ± 0.38 pA pF–1 at −80 mV (n = 7,
p = 0.0001 two-way ANOVA, Tukey’s comparisons test)
indicating that these currents were mediated by TRPC1
and required PKCδ activity.
Noradrenaline-evoked TRPC1 channels require PKCδ
The present study clearly demonstrates that the PKCδ
isoform is important for activation of TRPC1 channels
by agents that deplete internal Ca2+ stores. Therefore,
in the final series of experiments, we investigated the
physiological significance of these findings by examining
whether PKCδ is involved in activation of TRPC1
channels by the vasoconstrictor and α1-adrenoceptor
agonist methoxamine (MO). Figure 10 shows that,
in unstimulated VSMCs, there was a low level of
Figure 8. Store-operated interactions
between TRPC1 and PIP2 require PKCδ
A, representative images from freshly
isolated rat mesenteric VSMCs showing
expression of PIP2 (green) and TRPC1 (red)
following pretreatment with BAPTA-AM for
10 min, wortmannin (Wort) for 20 min and
δV1-TAT for 10 min. B, representative
images and mean data from PLA
experiments showing that control
interactions between TRPC1 and PIP2
(n = 23) were greatly increased by
pre-treatment with BAPTA-AM for 10 min
(n = 23, p = 0.0001), and this was reduced
by coapplication with δV1-TAT (n = 20,
p = 0.0001) and wortmannin (n = 19,
p = 0.0001, unpaired t test). Scale
bars = 10 μm.
Figure 9. PIP2 increases PDBu-induced whole-cell TRPC1 currents
A, mean I–V relationships from freshly isolated rat mesenteric artery VSMCs showing that bath application of PDBu
but not inclusion of diC8-PIP2 in the patch pipette solution induced a whole-cell current. B, mean I–V relationships
showing that, following cell dialysis with diC8-PIP2, PDBu-evoked whole-cell currents had a greatly increased peak
amplitude compared to currents induced by PDBu alone (A) and were inhibited by T1E3 and δV1-TAT.
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spontaneous 2 pS TRPC1-based channel activity in
cell-attached patches held at −80 mV, and that mean
peak open probability (NPo) was increased following
bath application of MO from 0.14 ± 0.07 to 0.51 ± 0.2
(n = 6, p = 0.0035) and was significantly reduced by sub-
sequent coapplication of δV1-TAT to 0.11 ± 0.08 (n = 6,
p = 0.0029, paired t test).
Discussion
The present study reveals that activity of PKCδ, a member
of the novel PKC isoform subgroup, is essential for
activation of TRPC1-based channels evoked by store
depletion and α1-adrenoceptor stimulation in native
contractile rat mesenteric artery VSMCs. It is proposed
that PKCδ-dependent phosphorylation of TRPC1 is
required for TRPC1 channel activation by PIP2, the
probable activating ligand. These results provide further
evidence that PKC activity and PIP2 are obligatory for
activation of TRPC1-based SOCs in VSMCs, ion channels
implicated in regulating contraction, proliferation and
migration that are processes linked to hypertension and
atherosclerosis. As such, regulating PKCδ activity and PIP2
levels may comprise therapeutic targets for these and other
vascular diseases.
TRPC1-based SOCs require PKC activity
Our results show that the well-established protocol
for inducing store depletion, the inclusion of a high
concentration of BAPTA in the patch pipette solution,
evoked a whole-cell non-selective cation current with a
relatively linear I–V relationship and an Erev of between
0 mV and +20 mV in freshly isolated rat mesenteric
artery VSMCs, which is similar to currents previously
recorded in rabbit and mouse VSMCs (Shi et al. 2012a,
2014, 2016, 2017a,b). Considerable evidence obtained
using pharmacological agents, antibodies as blocking
agents and TRPC1 knockout mice indicates that these
store-operated currents are mediated by a heteromeric
TRPC1/TRPC5 molecular template (Xu & Beech, 2001;
Xu et al. 2005a; Saleh et al. 2008; Shi et al. 2012a). In
further support of this proposal, the present study shows
that store-operated whole-cell currents were inhibited
by Pico145, a highly selective and potent TRPC1/C4/C5
channel blocker (Rubaiy et al. 2017) and T1E3, a TRPC1
antibody raised against an extracellular pore region and
known to act as a blocking agent (Xu & Beech, 2001;
Xu et al. 2005b). In addition, using PLA, the present study
reveals that TRPC1 and TRPC5 co-localize within <40 nm
of each other at (or close to) the plasma membrane of
VSMCs. It should be noted that the electrophysiological
and pharmacological properties of these store-operated
currents in freshly isolated VSMCs exhibiting a contra-
ctile phenotype are considerably different from those of
Orai1-based CRACs (Prakriya & Lewis, 2015), indicating
that Orai1 proteins are probably not involved, as reported
previously (Shi et al. 2017b).
Previous studies show that PKC activity and
PKC-mediated phosphorylation of TRPC1 are essential
for activation of TRPC1-based SOCs in native contra-
ctile VSMCs (Albert & Large, 2002b; Saleh et al.
2006, 2008; Large et al. 2009; Albert, 2011; Shi
et al. 2012a, 2014, 2016). The present study provides
further support for an excitatory role for PKC, with
the pan-PKC isoform selective inhibitor GF109203X
inhibiting store-operated whole-cell TRPC1 currents in
freshly isolated rat mesenteric artery VSMCs. Therefore,
identifying the specific PKC isoform responsible for
activating TRPC1-based SOCs was the main aim of the
present study.
PKCδ is the PKC isoform responsible for activation of
TRPC1-based SOCs and store-operated TRPC1
phosphorylation
The PKC family is subdivided into conventional PKC (α,
β and γ), novel PKC (δ, ϵ, η and θ) and atypical PKC (ζ
and ι/κ) isoforms (Salamanca & Khalil, 2005; Ringvold &
Khalil, 2017). Given that DAG analogues activate TRPC1
channels through a PKC-dependent mechanism in VSMCs
(Saleh et al. 2006; 2008; Large et al. 2009; Albert, 2011),
and that the Ca2+ store depletion protocols used to activate
TRPC1-based SOCs probably increase, decrease or do not
alter [Ca2+]i, the PKC isoform(s) responsible is probably
belongs to the novel subfamily (see Introduction).
Figure 10. Methoxamine-evoked TRPC1
channel activity is mediated by PKCδ
A and B, representative trace and mean
open probability (NPo) data showing that
bath application of methoxamine evoked
TRPC1 channel activity in cell-attached
patches held at −80 mV (n = 6,
p = 0.0035), which was reduced by
coapplication of δV1-TAT (n = 6,
p = 0.0029, paired t test).
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Western blotting and immunocytochemical analysis
demonstrated that PKCδ is expressed in native contra-
ctile rat mesenteric artery VSMCs and was distributed
at (or close to) the plasma membrane. There was greater
expression of PKCδ compared to other novel PKC isoforms
in VSMCs and tissue lysates; however, caution is warranted
when suggesting that PKCδ is the dominant novel PKC
isoform in VSMCs because expression variations may be
linked to potential differences between the affinity and
specificity of the anti-novel PKC isoform antibodies used.
Inhibition of PKCδ activity via well-characterized
selective PKCδ peptide inhibitors and knockdown of
PKCδ expression using morpholino oligomers resulted
in a significant reduction in the development and
peak amplitude of store-operated whole-cell TRPC1
currents. Moreover, immunoprecipitation and PLA
studies revealed that store depletion induced interactions
between TRPC1 and PKCδ. Importantly, PLA experiments
showed that store depletion induced puncta formation
between anti-TRPC1 and anti-phosphorylated serine
and threonine antibodies that was greatly reduced by
PKCδ peptide inhibitors and PKCδ selective morpholino
oligomers, which indicates that store depletion induces
PKCδ-dependent phosphorylation of TRPC1. Taken
together, these findings provide strong evidence for
the PKCδ isoform being essential in the activation of
TRPC1-based SOCs in native contractile VSMCs.
PKCδ has also been reported to participate in
store-operated Ca2+ entry in airway smooth muscle
(Gao et al. 2012), proliferation and migration of VSMCs
(Ding et al. 2011; Fan et al. 2014), development of
the myogenic response (Kashihara et al. 2008), and
membrane insertion of TRPM4 channels and associated
vasoconstriction (Crnich et al. 2010; Garcia et al. 2011).
Interestingly, TRPC1 has also been associated with many
of these vascular functions (Earley & Brayden, 2015) and,
accordingly, in the future, it may be useful to investigate
the functional association between TRPC1 and PKCδ
activities in the vasculature. By contrast to the results
outlined above, PKC activity has an inhibitory action
on Orai1-based CRACs with PKC inhibitors including
GF109203X and knockdown of PKCβ isoform increasing
Orai1 activity (Kawasaki et al. 2010), which further
indicates that Orai1 proteins or Orai1-based CRACs are
not involved in the activation of TRPC1-based SOCs in
native contractile VSMCs.
PKCδ activity is required for PIP2-mediated activation
of TRPC1 channels
We have previously described the obligatory requirement
of PIP2 in the activation of TRPC1-based SOCs and
proposed that PKC-dependent phosphorylation of TRPC1
is required for this phospholipid to act as the activating
ligand (Large et al. 2009; Saleh et al. 2009a,b; Albert,
2011; Shi et al. 2012a,b, 2014). In the present study, using
PLA, store depletion induces interactions between PIP2
and TRPC1 at (or close to) the plasma membrane of
VSMCs that are reduced by PKCδ peptide inhibitor. To
provide evidence that endogenous PIP2 is involved in
these results, we showed that a high concentration of
wortmannin (20μM) that depletes PIP2 levels by inhibiting
PI-4/PI-5 kinase-mediated PIP2 synthesis (Suh & Hille,
2005) reduced PIP2 immunostaining and store-operated
associations between TRPC1 and PIP2. It should be
noted that a high concentration of wortmannin also
inhibits myosin light chain kinase (MLCK) and PI(3)
kinase, although previous findings have shown that lower
concentrations (<1 μM) inhibiting MLCK and PI-3 kinase
but not depleting PIP2 levels had no effect on activation of
TRPC1 channel activity in VSMCs (Saleh et al. 2009a; Shi
et al. 2014). The PKC activator PDBu activated whole-cell
TRPC1 currents that were increased in amplitude when
the water soluble PIP2 analogue diC8-PIP2 was included
in the patch pipette solution and were inhibited by a PKCδ
peptide inhibitor. Cell dialysis with diC8-PIP2 failed to
activate any whole-cell currents on its own, as reported
previously (Albert et al. 2008), which indicates that the
effects of PDBu and PIP2 are not merely additive but
probably represent synergism between the two molecules.
Taken together, these results re-enforce the idea that PIP2 is
the activating ligand of TRPC1-based SOCs, and that this
requires PKCδ-dependent phosphorylation of TRPC1.
The proposed excitatory roles of PKC and PIP2 on
TRPC1-based SOCs are opposite to the action of these
molecules in the activation of non-TRPC1-containing
channels (e.g. TRPC3/C6/C7 channels) in native contra-
ctile VSMCs (Venkatachalam et al. 2003; Albert & Large,
2004; Large et al. 2009; Shi et al. 2010; Albert, 2011). This
subgroup of TRPC channels, known as receptor-operated
channels (ROCs), is activated by receptor-mediated
generation of DAG, which leads to channel opening
via PKC independent mechanisms, with subsequent
PKC activity induced by DAG producing channel
inhibition. Interestingly, stimulation of TRPC1-based
SOCs is proposed to inhibit TRPC6-based SOCs through
inducing Ca2+ influx and PKC activity, which suggests
the involvement of a conventional PKC isoform (Shi et al.
2010). A distinct role of PIP2 on TRPC3/C6/C7-based
ROCs is less clear, with both inhibitory and excitatory
actions on channel activity being proposed (Albert et al.
2008; Imai et al. 2012). These findings further indicate
that TRPC1-based SOCs and TRPC3/C6/C7-based ROCs
form distinct channel structures with differing activation
mechanisms involving differing PKC isoforms, and
probably distinct functions in VSMCs.
Computation predication of potential PKCδ-dependent
phosphorylation sites within the TRPC1 sequence using
GPS 3.0 (Xue et al. 2008) reveals five intracellular serine
residues, with Ser619 and Ser752 at the C-terminal domain
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being of significance in that both of these sites are close to a
known PIP2-binding domain (Kwon et al. 2007). Hence, it
is possible that PKCδ-dependent phosphorylation of one
or both sites increases PIP2 binding to TRPC1, leading
to channel opening. Other studies have demonstrated
that protein kinase A, protein kinase G and calmodulin
kinase II have inhibitory actions on TRPC1-based SOCs
in VSMCs (Liu et al. 2005a; Albert et al. 2006; Chen et al.
2011), and therefore TRPC1 phosphorylation by these
kinases might inhibit TRPC1-based SOCs by reducing
TRPC1 and PIP2 interactions. Similar roles for kinase
activities with respect to modulating lipid–protein inter-
actions are well-established in the regulation of K+ channel
subtypes (Logothetis et al. 2015).
One important aspect is how PKCδ activity is stimulated
by store depletion. Our proposed hypothesis based on
previous work indicates that store depletion induces
STIM1–TRPC1 interactions, which stimulate a Gq-PLCβ1
pathway that generates DAG and PKC activity, leading
to PKC-dependent phosphorylation of TRPC1 (Baudel,
2020). PKC-dependent phosphorylation of TRPC1 leads
to a dissociation of interactions between TRPC1 and the
PIP2 binding protein myristoylated alanine-rich C-kinase
substrate (MARCKS), with the latter molecule then
releasing PIP2 into the local environment, allowing it to
act as the channel activating ligand. The present study
indicates that the PKCδ isoform is probably an essential
PKC isoform in this process and this will be important to
investigate in detail in future studies.
Physiological relevance of PKCδ-mediated TRPC1
channels
TRPC1 channel activity induced by the α1-adrenoceptor
agonist and vasoconstrictor methoxamine was reduced
by a PKCδ peptide inhibitor, which suggests that a
similar store-operated activation process involving PKCδ
may be used by physiological stimulants of TRPC1
channels. This is further supported by findings showing
that PLCβ1 and STIM1 knockdown both significantly
inhibit noradrenaline-evoked TRPC1 channel activity
(Shi et al. 2016, 2017b) and noradrenaline induces an
increase in PKC-dependent phosphorylation of TRPC1
and stimulates MARCKS to release PIP2, which is then
available to interact with TRPC1 (Shi et al. 2014). It
was previously proposed that vasoconstrictor agents may
also activate TRPC1-based SOCs independently of store
deletion (Albert & Large, 2002b; Saleh et al. 2006; Large
et al. 2009; Saleh et al. 2009b; Shi et al. 2010, 2012b; Albert,
2011), which suggests that TRPC1 channels may also act as
ROCs. The current and previous findings certainly suggest
that a significant contribution to physiological stimulation
of TRPC1 channels probably occurs via a store-operated
pathway.
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